A CRO for Small and Medium Sized Biotech Companies. Argint International Clinical Research and Development Services (Argint) is a privately owned, regional CRO, providing clinical research services throughout Europe. Argint is focused on providing tailor made full-service solutions to small and medium sized biotech companies, partnering clients as they bring their drug candidates or devices into the clinical phase.
Argint supports the planning and execution of our client's development programs: from initial consultancy through phase I, POC and larger phase II and phase III studies. Argint provides a "one-stop shop" for all clinical outsourcing needs in Europe. Our clients enter into a single contract with Argint and we construct the most suitable team to deliver the study you are planning from specialist vendors and manage the study for you, and with you, as your European partner.
We have found Argint very knowledgeable of the centers that are available for clinical trials, forming good relationships with the sites. They are proficient in study set up and conduct of the clinical trial. They are proactive, fast, effective and very collaborative. It is a great pleasure to work with them and I have no hesitation to recommend them to other potential clients.
Having been actively managing trials in Poland for almost 8 years, we are happy to officially open Argint International Sp. z.o.o. in Warsaw.
Having 16 MDs (with various specialisations) and >20 pharmacists on staff enables us to easily adapt to new therapeutic areas. We recently analysed our activities in 2016.